Evidence map›Paper›PMID 27814769›Full record

ArticleGenome medicine2016

Somatic cancer variant curation and harmonization through consensus minimum variant level data.

Deborah I Ritter, Sameek Roychowdhury, Angshumoy Roy, Shruti Rao, Melissa J Landrum, Dmitriy Sonkin, Mamatha Shekar, Caleb F Davis, Reece K Hart, Christine Micheel and 9 more

Abstract readConsensus Statement
In one paragraph

Article in Genome medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Clinical cancer genomic profiling.Nature reviews. Genetics · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): lessons learned and plans for the future.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Deborah I RitterBaylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Sameek RoychowdhuryOhio State University, Columbus, OH, USA.
Angshumoy RoyBaylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Shruti RaoInnovation Center for Biomedical Informatics and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Melissa J LandrumNational Center for Biotechnology Information, Bethesda, MD, USA.
Dmitriy SonkinNational Cancer Institute, Rockville, MD, USA.
Mamatha ShekarIllumina, San Diego, CA, USA.
Caleb F DavisMolecularMatch, Houston, TX, USA.
Reece K HartInvitae, San Francisco, CA, USA.
Christine MicheelVanderbilt University School of Medicine, Nashville, TN, USA.
Meredith WeaverAmerican College of Medical Genetics and Genomics, Bethesda, MD, USA.
Eliezer M Van AllenDana-Farber Cancer Institute, Boston, MA, USA.
Donald W ParsonsBaylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Howard L McLeodMoffitt Cancer Center, Tampa, FL, USA.
Michael S WatsonAmerican College of Medical Genetics and Genomics, Bethesda, MD, USA.
Sharon E PlonBaylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Shashikant KulkarniBaylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Subha MadhavanInnovation Center for Biomedical Informatics and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA. sm696@georgetown.edu.
ClinGen Somatic Cancer Working Group

Funding

Resource ProjectU41HG006834 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI REHM, HEIDI L · 2013 to 2020
$26.9M
Measuring Perceptions of Utility of Clinical Genome Sequencing: Instrument Testing and ValidationU01HG006485 · NHGRI · BAYLOR COLLEGE OF MEDICINE · PI MCGUIRE, AMY L, PARSONS, DONALD W. · 2012 to 2021
$22.1M
The Clinical Genome Resource - Expert Curation and EHR IntegrationU41HG009650 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S · 2017 to 2020
$13.3M
Clinically Relevant Genome Variation DatabaseU01HG007436 · NHGRI · STANFORD UNIVERSITY · PI BUSTAMANTE, CARLOS DANIEL, PLON, SHARON E. · 2013 to 2016
$10.5M
A Knowledge Base for Clinically Relevant Genes and VariantsU01HG007437 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERG, JONATHAN S, EVANS, JAMES PHILIP · 2013 to 2016
$9.0M
The Use of Whole-Exome Sequencing to Guide the Care of Cancer PatientsU01HG006492 · NHGRI · DANA-FARBER CANCER INST · PI JANNE, PASI A, VAN ALLEN, ELIEZER M · 2012 to 2016
$7.3M
MACE2K - Molecular And Clinical Extraction: A Natural Language Processing Tool for Personalized MedicineU01HG008390 · NHGRI · GEORGETOWN UNIVERSITY · PI MADHAVAN, SUBHA · 2015 to 2017
$1.5M
Resistance to Emerging Androgen Deprivation Therapies in Prostate CancerK08CA188615 · NCI · DANA-FARBER CANCER INST · PI VAN ALLEN, ELIEZER M · 2014 to 2017
$708k
NCI NIH HHS K08 CA188615NHGRI NIH HHS U01 HG006485NHGRI NIH HHS U01 HG006492NHGRI NIH HHS U01 HG007436NHGRI NIH HHS U01 HG007437NHGRI NIH HHS U01 HG008390NHGRI NIH HHS U41 HG006834
6 · The paper itself

Abstract

backgroundTo truly achieve personalized medicine in oncology, it is critical to catalog and curate cancer sequence variants for their clinical relevance. The Somatic Working Group (WG) of the Clinical Genome Resource (ClinGen), in cooperation with ClinVar and multiple cancer variant curation stakeholders, has developed a consensus set of minimal variant level data (MVLD). MVLD is a framework of standardized data elements to curate cancer variants for clinical utility. With implementation of MVLD standards, and in a working partnership with ClinVar, we aim to streamline the somatic variant curation efforts in the community and reduce redundancy and time burden for the interpretation of cancer variants in clinical practice.

methodsWe developed MVLD through a consensus approach by i) reviewing clinical actionability interpretations from institutions participating in the WG, ii) conducting extensive literature search of clinical somatic interpretation schemas, and iii) survey of cancer variant web portals. A forthcoming guideline on cancer variant interpretation, from the Association of Molecular Pathology (AMP), can be incorporated into MVLD.

resultsAlong with harmonizing standardized terminology for allele interpretive and descriptive fields that are collected by many databases, the MVLD includes unique fields for cancer variants such as Biomarker Class, Therapeutic Context and Effect. In addition, MVLD includes recommendations for controlled semantics and ontologies. The Somatic WG is collaborating with ClinVar to evaluate MVLD use for somatic variant submissions. ClinVar is an open and centralized repository where sequencing laboratories can report summary-level variant data with clinical significance, and ClinVar accepts cancer variant data.

conclusionsWe expect the use of the MVLD to streamline clinical interpretation of cancer variants, enhance interoperability among multiple redundant curation efforts, and increase submission of somatic variants to ClinVar, all of which will enhance translation to clinical oncology practice.

Indexed as

Genetic VariationAlgorithmsDatabases, GeneticData CurationGene FrequencyHumansNeoplasmsPrecision MedicineCancer genomicsData standardSomatic variant curationSomatic variant interpretation

Identifiers

PMID27814769
PMCPMC5095986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.